Estimated costs of managing treatment-related adverse events (TRAEs) of nivolumab (nivo) and docetaxel (doc) in the CheckMate 017 and CheckMate 057 phase III non-small cell lung cancer (NSCLC) trials

被引：1

作者：

Venkatachalam, Meena

Stenehjem, David D.

Pietri, Guilhem

Penrod, John R.

Korytowsky, Beata

机构：

[1] Parexel, Waltham, MA USA

[2] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA

[3] Bristol Myers Squibb, Princeton, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.6617

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6617

引用

页数：4

共 50 条

[21] Lung Cancer Symptom Scale (LCSS) as a marker of treatment (tx) benefit with nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC from CheckMate 057. [J].

Gralla, Richard J. ;

Spigel, David R. ;

Bennett, Bryan ;

Taylor, Fiona ;

Penrod, John R. ;

DeRosa, Michael ;

Dastani, Homa ;

Orsini, Lucinda Strycker ;

Reck, Martin .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[22] Estimated costs of grade 3-4 all-cause and treatment-related adverse events for stage IV or recurrent non-small cell lung cancer (NSCLC) in the CheckMate 227 (CM-227) trial. [J].

Stenehjem, David D. ;

Santi, Irene ;

Gupte-Singh, Komal ;

Penrod, John R. ;

Venkatachalam, Meena .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)

[23] CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC) [J].

Wu, Y. ;

Chang, J. ;

Zhang, L. ;

Tu, H. ;

Wu, L. ;

Feng, J. ;

Lu, S. ;

Zhou, C. ;

Wang, J. ;

Mok, T. ;

Taylor, F. ;

Mossman, B. ;

Penrod, J. ;

Lawrance, R. ;

Blum, S. ;

Wang, P. F. ;

Cheng, Y. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) :S1047-S1048

[24] Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057 [J].

Reck, Martin ;

Brahmer, Julie ;

Bennett, Bryan ;

Taylor, Fiona ;

Penrod, John R. ;

DeRosa, Michael ;

Dastani, Homa ;

Spigel, David R. ;

Gralla, Richard J. .

EUROPEAN JOURNAL OF CANCER, 2018, 102 :23-30

[25] Phase 3, randomized trial (CheckMate 057) of nivolumab vs docetaxel in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): subgroup analyses and patient reported outcomes (PROs) [J].

Horn, L. ;

Brahmer, J. ;

Reck, M. ;

Borghaei, H. ;

Spigel, D. R. ;

Steins, M. ;

Ready, E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Burgio, M. A. ;

Fayette, J. ;

Gettinger, S. N. ;

Harbison, C. T. ;

Li, A. ;

Finckenstein, F. G. ;

Paz-Ares, L. .

ANNALS OF ONCOLOGY, 2015, 26 :125-125

[26] Adverse events related to nivolumab in non-small cell lung cancer (NSCLC): a retrospective observational study [J].

Sassier, M. ;

Oulkhouir, Y. ;

Gervais, R. ;

Alexandre, J. ;

Humbert, X. ;

Coquerel, A. ;

Fedrizzi, S. .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 :31-32

[27] Evaluation of disease-related symptoms in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC) treated with nivolumab (NIVO) or docetaxel (DOC) [J].

Gralla, R. J. ;

Coon, C. ;

Taylor, F. ;

Penrod, J. R. ;

DeRosa, M. ;

Dastani, H. ;

Orsini, L. ;

Reck, M. .

Oncology Research and Treatment, 2015, 38 :14-+

[28] Impact of of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer: Results from the CheckMate 017 Study [J].

Reck, Martin ;

Taylor, Fiona ;

Penrod, John R. ;

DeRosa, Michael ;

Morrissey, Laura ;

Dastani, Homa ;

Orsini, Lucinda ;

Gralla, Richard J. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (02) :194-204

[29] Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study [J].

Wu, Yi-Long ;

Lu, Shun ;

Cheng, Ying ;

Zhou, Caicun ;

Wang, Jie ;

Mok, Tony ;

Zhang, Li ;

Tu, Haiyan ;

Wu, Lin ;

Feng, Jifeng ;

Zhang, Yiping ;

Luft, Alexander Valeriercich ;

Zhou, Jianying ;

Ma, Zhiyong ;

Lu, You ;

Hu, Chengping ;

Shi, Yuankai ;

Baudelet, Christine ;

Li, Zoe ;

Chang, Jianhua .

CANCER RESEARCH, 2018, 78 (13)

[30] Checkmate 384: A Phase 313/4 Dose Frequency Optimization Trial of Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [J].

Harris, Ronald ;

Reinmuth, Niels ;

Mitche, Paul ;

Zhu, Jin ;

Chang, I-Fen ;

Pichons, Eric .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S1298-S1299

← 1 2 3 4 5 →